Cephapirin for Cow: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Cephapirin is a first-generation cephalosporin antibiotic used in cattle, most often as an intramammary infusion for mastitis. In the U.S., the best-known products are cephapirin sodium for lactating cows and cephapirin benzathine for dry cows. These products are placed directly into the teat canal and udder quarter rather than given by mouth.

Cephapirin is used because it targets many gram-positive mastitis pathogens, especially Streptococcus agalactiae and Staphylococcus aureus on labeled products. It is not a one-size-fits-all antibiotic, though. Response depends on the organism involved, whether the case is mild or severe, and whether the infection is new, chronic, or recurring.

For food-producing animals, label details matter a great deal. Your vet will consider the exact product, whether the cow is lactating or dry, and the required milk and meat withdrawal times before treatment starts. That helps protect both the cow and the food supply.

Cephapirin is used primarily for bovine mastitis, but the exact use depends on the formulation. Cephapirin sodium is labeled for mastitis in lactating cows caused by susceptible strains of Streptococcus agalactiae and Staphylococcus aureus, including penicillin-resistant strains. Cephapirin benzathine products are used in dry cows at dry-off as part of a mastitis treatment program.

In practice, your vet may choose cephapirin when the herd history, milk culture, or quarter-level findings suggest a pathogen that is likely to respond. Merck notes that on-farm or clinic-based milk culture can help separate gram-positive from gram-negative infections, which can guide mastitis decisions more thoughtfully.

Cephapirin is not the right fit for every udder infection. Severe mastitis, recurrent mastitis, yeast mastitis, or cases with systemic illness may need a different plan. If a cow has fever, dehydration, weakness, or a toxic appearance, see your vet immediately because supportive care and a broader treatment plan may be needed.

For lactating cows, the labeled cephapirin sodium dose is one 10 mL intramammary syringe containing 200 mg cephapirin sodium into each infected quarter immediately after the quarter has been completely milked out. The label states do not milk out for 12 hours, then repeat once only in 12 hours. Milk from treated animals must be withheld during treatment and for 96 hours after the last treatment, and treated animals must not be slaughtered for food until 4 days after the last treatment.

For dry cows, cephapirin benzathine products are different drugs in a different production stage. A common labeled dry-cow product contains 300 mg cephapirin in 10 mL for intramammary infusion into the dry cow. Dry-cow therapy is given at dry-off, not during lactation, and the withdrawal directions are product-specific. Your vet should confirm the exact label and timing relative to calving.

Because this is a food-animal antibiotic, your vet should direct the exact product choice, quarter selection, infusion technique, and recordkeeping. Clean teat-end preparation matters. Poor infusion hygiene can introduce new organisms into the udder, and repeated or inappropriate intramammary treatment can make chronic cases harder to manage.

Most cows tolerate intramammary cephapirin well when it is used exactly as labeled, but side effects and treatment problems can still happen. The most common concerns are local irritation, continued abnormal milk, lack of improvement, or recurrence later in lactation. A cow that does not improve may have a resistant infection, a chronic infection, or a pathogen that is not a good match for this drug.

As with other beta-lactam antibiotics, allergic or hypersensitivity reactions are possible, although they are not common. If a cow develops swelling, hives, sudden distress, or collapse after treatment, see your vet immediately.

Another practical risk is not a drug reaction but a management complication: contamination during infusion. Merck notes that poor infusion asepsis and repeated intramammary antimicrobial use can contribute to unusual or difficult mastitis cases, including yeast or environmental infections. If milk becomes more abnormal, the quarter worsens, or the cow develops fever or reduced appetite, contact your vet promptly.

There are no widely emphasized day-to-day drug interactions unique to cephapirin in cattle that pet parents can safely manage on their own, but your vet still needs a full medication history. That includes other intramammary products, systemic antibiotics, anti-inflammatories, teat sealants, and any recent dry-cow therapy.

The biggest real-world concern is using cephapirin alongside other udder treatments without a clear plan. Combining products can complicate withdrawal times, make treatment records harder to follow, and increase the risk of residue violations if label directions are not followed exactly.

Your vet will also think about whether another antibiotic could interfere with culture interpretation or whether repeated antimicrobial exposure may reduce the value of continued treatment in a chronic quarter. In food animals, the safest approach is to use the exact labeled product, route, frequency, and duration your vet recommends and to document every treatment carefully.